Ajooni Biotech Limited (NSE:AJOONI)
India · Delayed Price · Currency is INR 3.770
-0.060 (-1.57%)
Jun 19, 2026, 3:29 PM IST
Ajooni Biotech Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 43.22 | 33.72 | 21.61 | 11.25 | 10.49 |
Depreciation & Amortization | 22.06 | 10.94 | 8.74 | 10.05 | 9.7 |
Other Amortization | - | - | - | - | 1.41 |
Loss (Gain) From Sale of Assets | -0.93 | -0.02 | - | 0 | 0.11 |
Other Operating Activities | 8.86 | -4.71 | 3.48 | 3.84 | 7.95 |
Change in Accounts Receivable | -16.18 | -32.57 | 75.92 | -67.11 | -1.29 |
Change in Inventory | -154.68 | -86.2 | -7.37 | -11.12 | -5.06 |
Change in Accounts Payable | 54.19 | 19.11 | 85.27 | 33.12 | 13.99 |
Change in Other Net Operating Assets | -13.88 | -117.63 | 41.46 | -35.82 | -0.47 |
Operating Cash Flow | -57.34 | -177.37 | 229.1 | -55.79 | 36.84 |
Operating Cash Flow Growth | - | - | - | - | 218.74% |
Capital Expenditures | -180.28 | -20.32 | -56.02 | -13.6 | -21.24 |
Sale of Property, Plant & Equipment | 11.92 | 9.56 | 0.34 | 0.04 | 0.99 |
Sale (Purchase) of Real Estate | - | - | - | -15 | - |
Investment in Securities | -1.95 | -169.46 | 127.03 | -131.73 | 1.27 |
Other Investing Activities | 12.6 | 8.88 | 5.01 | 2.05 | 0.01 |
Investing Cash Flow | -157.71 | -171.34 | 76.37 | -158.24 | -18.97 |
Short-Term Debt Issued | 162.23 | - | - | 6.56 | - |
Long-Term Debt Issued | - | 2.58 | - | - | 6.79 |
Total Debt Issued | 162.23 | 2.58 | - | 6.56 | 6.79 |
Short-Term Debt Repaid | - | -4.86 | -29.45 | - | -21.12 |
Long-Term Debt Repaid | -4 | - | -0.65 | -8.3 | - |
Total Debt Repaid | -4 | -4.86 | -30.09 | -8.3 | -21.12 |
Net Debt Issued (Repaid) | 158.23 | -2.28 | -30.09 | -1.74 | -14.33 |
Issuance of Common Stock | - | 253.89 | - | 223.07 | - |
Other Financing Activities | -7.29 | -3.34 | -5.57 | -4.78 | -5.4 |
Financing Cash Flow | 150.94 | 248.26 | -35.66 | 216.55 | -19.73 |
Miscellaneous Cash Flow Adjustments | - | - | -0 | - | 0 |
Net Cash Flow | -64.11 | -100.45 | 269.81 | 2.52 | -1.87 |
Free Cash Flow | -237.62 | -197.69 | 173.09 | -69.39 | 15.6 |
Free Cash Flow Margin | -12.86% | -17.06% | 21.57% | -9.32% | 2.11% |
Free Cash Flow Per Share | -1.38 | -1.15 | 1.98 | -1.16 | 0.31 |
Cash Interest Paid | 7.29 | 3.34 | 5.57 | 4.78 | 5.4 |
Cash Income Tax Paid | - | 8.75 | 5.42 | 4.48 | 1.57 |
Levered Free Cash Flow | -252.56 | -190.08 | -106.59 | -69.14 | 13 |
Unlevered Free Cash Flow | -248 | -190.08 | -106.59 | -69.14 | 13 |
Change in Working Capital | -130.55 | -217.29 | 195.27 | -80.93 | 7.18 |